SOURCE: Alpharma Inc.

November 26, 2007 14:14 ET

Alpharma to Host Investor Meeting December 18, 2007

BRIDGEWATER, NJ--(Marketwire - November 26, 2007) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, will be hosting an Investor Meeting at 3:00PM on Tuesday, December 18, 2007 at The Four Seasons Hotel in New York City. Registration will begin at 2:30PM. This presentation will be webcast in a listen only mode and can be accessed via the Internet at

Alpharma press releases and the December 18, 2007 investor presentation can be accessed through Alpharma's website, through its Investor Support and Company Calendar tabs.

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and an innovative pharmaceutical product pipeline that consists of several novel approaches to treat pain, including the FLECTOR® Patch (diclofenac epolamine topical patch), which is expected to launch in early 2008. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information